Peter Fitzgerald - Profile and Investment Details

Investor Profile

Peter Fitzgerald is a Venture Capital based in San Ramon, California, United States with a diverse investment portfolio that includes companies such as Calistoga Pharmaceuticals, Pathway Medical Technologies, Femta Pharmaceuticals, Neuraltus Pharmaceuticals, Inova Labs, Naurex, Aptinyx, Pulmonx, CardioMind, Meritage Pharma, Ovalis, XTENT, Proteolix, Aria Biosystems, Leptos Biomedical, Talima Therapeutics, Transcend Medical, TetraLogic PharmaceuticalsBayhill Therapeutics, ProteinSimple, Viracta Therapeutics, OncoMed Pharmaceuticals, . Over time, Peter Fitzgerald has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Peter Fitzgerald is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Biotechnology, Research, Medical, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Peter Fitzgerald, as their portfolio suggests a familiarity and interest in this area.

Understanding Peter Fitzgerald’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.